BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21940908)

  • 21. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M; Troncoso P; Bruns C; Bar-Eli M
    Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
    Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
    Mitsui Y; Chang I; Kato T; Hashimoto Y; Yamamura S; Fukuhara S; Wong DK; Shiina M; Imai-Sumida M; Majid S; Saini S; Shiina H; Nakajima K; Deng G; Dahiya R; Tanaka Y
    Oncotarget; 2016 Aug; 7(31):49107-49121. PubMed ID: 27203547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands.
    Desouki MM; Geradts J; Milon B; Franklin RB; Costello LC
    Mol Cancer; 2007 Jun; 6():37. PubMed ID: 17550612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
    Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y
    Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of DNA-methylation on zinc homeostasis in myeloid cells: Regulation of zinc transporters and zinc binding proteins.
    Kessels JE; Wessels I; Haase H; Rink L; Uciechowski P
    J Trace Elem Med Biol; 2016 Sep; 37():125-133. PubMed ID: 26905204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.
    Kron K; Pethe V; Briollais L; Sadikovic B; Ozcelik H; Sunderji A; Venkateswaran V; Pinthus J; Fleshner N; van der Kwast T; Bapat B
    PLoS One; 2009; 4(3):e4830. PubMed ID: 19283074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
    Dasari VK; Deng D; Perinchery G; Yeh CC; Dahiya R
    J Urol; 2002 Jan; 167(1):335-8. PubMed ID: 11743352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells.
    Milon BC; Agyapong A; Bautista R; Costello LC; Franklin RB
    Prostate; 2010 Feb; 70(3):288-96. PubMed ID: 19802870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas.
    Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W
    PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.
    Sørensen KD; Abildgaard MO; Haldrup C; Ulhøi BP; Kristensen H; Strand S; Parker C; Høyer S; Borre M; Ørntoft TF
    Br J Cancer; 2013 Feb; 108(2):420-8. PubMed ID: 23322201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.
    Menschikowski M; Hagelgans A; Kostka H; Eisenhofer G; Siegert G
    Neoplasia; 2008 Nov; 10(11):1195-203. PubMed ID: 18953428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.